Abstract
Repeated exposure of rats to the psychotomimetic drug phencyclidine (PCP) markedly increased the response of prefrontal cortical neurons to the glutamate agonist N-methyl-d-aspartate (NMDA) relative to agonist α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid. Moreover, acute challenge by PCP produced a significantly reduced block of NMDA-induced current. In addition, the subchronic administration of PCP reduced significantly the paired-pulse facilitation, accompanied by a significant increase of excitatory postsynaptic current variance. These results suggest that repeated exposure to PCP increased evoked release of excitatory amino acids. The enhanced release of excitatory amino acids evoked by NMDA could explain, at least partly, a hypersensitive response to NMDA and a reduced blockade of the NMDA responses by a PCP challenge in rats exposed repeatedly to PCP. Pretreatment with the atypical antipsychotic drug clozapine, but not the typical antipsychotic drug haloperidol, attenuates the repeated PCP-induced effect. Our results support the hypothesis that clozapine may facilitate NMDA receptor-mediated neurotransmission to improve schizophrenic-negative symptoms and cognitive dysfunction. This novel approach is useful for evaluating the cellular mechanisms of action of atypical antipsychotic drugs.
Footnotes
-
Send reprint requests to: Rex Y. Wang, Ph.D., Department of Psychiatry and Behavioral Sciences, SUNY, Putnam Hall, South Campus, Stony Brook, NY 11794-8790. E-mail: rex.wang{at}sunysb.edu.
-
↵1 This research was supported by U.S. Public Health Service Grant MH-41440.
- Abbreviations:
- PCP
- phencyclidine
- ACSF
- artificial cerebrospinal fluid
- AMPA
- (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
- APD
- antipsychotic drug
- EAA
- excitatory amino acid
- EPSC
- excitatory postsynaptic current
- mcv EPSC variance = Mean2/[SD]2
- MK-801, dizocilpine
- mPFC
- medial prefrontal cortex
- NMDA
- N-methyl-d-aspartate
- PPF
- paired-pulse facilitation
- Accepted December 23, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|